Opko Health (OPK) Cash from Financing Activities (2010 - 2026)

Opko Health (OPK) has reported Cash from Financing Activities for 17 consecutive years, with -$5.2 million the latest figure, recorded in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$5.2 million, down 28.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$119.2 million (down 145.89% YoY), and the FY2025 annual result was -$118.1 million, down 164.1% from the prior year.
• Cash from Financing Activities was -$5.2 million for Q1 2026 at Opko Health, up from -$18.3 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $224.6 million in Q3 2024 and troughed at -$79.5 million in Q2 2025.
• Average Cash from Financing Activities over 5 years is $9.5 million, with a median of -$823000.0 recorded in 2023.
• Year-over-year, Cash from Financing Activities jumped 10571.64% in 2024 and tumbled 529.72% in 2025.
• Over 5 years, Cash from Financing Activities stood at $10.1 million in 2022, then plunged by 136.98% to -$3.8 million in 2023, then soared by 6088.75% to $224.6 million in 2024, then tumbled by 108.16% to -$18.3 million in 2025, then surged by 71.88% to -$5.2 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$5.2 million in Q1 2026, -$18.3 million in Q4 2025, and -$16.2 million in Q3 2025.